DEBI BOERAS, PH.DFounder & CEO

The Global Health Impact Group started by Debi Boeras in 2014 was formed in response to the need for stronger partnerships to meet global HIV targets. Debi brings with her over 10 years of HIV experience as a molecular virologist at Emory University Yerkes Primate Research Center and then as the Lead for Molecular Diagnostics at the International Laboratory Branch, Centers for Disease Control and Prevention. In Debi’s experience, the most efficient and effective approach to ensure successful programs in HIV diagnosis and monitoring is through strong collaborations. Debi continues to work closely with the African Society for Laboratory Medicine (ASLM), CDC and PEPFAR, Clinton Health Access Initiative (CHAI) and Doctors Without Borders (MSF), UNAIDS, UNITAID and the World Health Organization (WHO), providing laboratory and programmatic technical expertise to ensure sustainable country-owned health care programs and health systems.

Laura Broyles, MD – Chief of Programs

Laura Broyles, MD is a board-certified infectious diseases physician with over 15 years experience in global HIV programs and clinical HIV care. Her work has included HIV viral load monitoring, early infant diagnosis, HIV drug resistance surveillance and research, elimination of mother-to-child transmission of HIV, differentiated service delivery for PLHIV, and ensuring quality HIV services at the facility level. Prior to joining GHIG, Laura spent eight years in the Division of Global HIV and TB (DGHT) at CDC headquarters in Atlanta, where she served most recently as Chief of the Maternal and Child Health Branch. Dr. Broyles served as an Epidemic Intelligence Service Officer in the CDC Division of HIV/AIDS Prevention from 2001-2003 after completing residency in internal medicine. She has been on the faculty of the Emory University Division of Infectious Diseases since 2006 and continues to do clinical work at the Grady Infectious Diseases Program.

ROBERT LUO, MD, MPH – Chief Medical Officer

Dr. Robert Luo, MD, MPH is a board-certified pathologist who has worked on diagnostics over the last 15 years across academia, public health, and industry. Dr. Luo received his BA from Harvard University and his MD and MPH from Johns Hopkins University, before completing his residency training in anatomic and clinical pathology at Stanford University. After residency, he worked at the US Centers for Disease Control and Prevention, Stanford University Medical Center, and most recently at Roche Molecular Diagnostics, where he served as a medical director for over 10 new diagnostic assays. His work on diagnostics and infectious diseases has been published in JAMA, Lancet, and numerous other scientific journals. He has lived and worked in a variety of settings, including the US, South Africa, China, Kenya, India, Peru, Vietnam, Malaysia, and North Korea.